April 4, 2019
April 4, 2019 —
An international team of scientists led by researchers at University of California San Diego School of Medicine employed an array of next-generation sequencing and gene-editing tools, such as CRISPR, to map the molecular dependencies – and thus vulnerabilities – of pancreatic cancer stem cells.
April 1, 2019
April 1, 2019 —
Moores Cancer Center at UC San Diego Health treats the first patient treated for cancer with a human-induced pluripotent stem cell (iPSC)-derived cell therapy called FT500. Dan Kaufman collaborated with Fate Therapeutics to bring the iPSC-derived natural killer cell cancer immunotherapy to patients.
March 29, 2019
March 29, 2019 —
In a study of people with nonalcoholic fatty liver disease and their twins and other close relatives, UC San Diego researchers were able to diagnose liver cirrhosis simply by analyzing a person’s stool microbes.
March 28, 2019
March 28, 2019 —
Researchers at University of California San Diego School of Medicine, with colleagues elsewhere, report on a novel four-year, randomized clinical trial evaluating different home-based methods to assess cognitive function and decline in participants over the age of 75.
March 28, 2019
March 28, 2019 —
Developing how the heart forms and brain works. How to analyze sarcasm computationally. Harnessing computers to develop campaign rhetoric across the spectrum.
Halıcıoğlu Data Science Institute announced innovative undergraduate research scholarship projects across academic disciplines.
March 20, 2019
March 20, 2019 —
UC San Diego School of Medicine research sets the stage for clinicians to potentially one day use levels of a pancreatic cancer patient’s PHLPP1 and PKC enzymes as a prognostic, and for researchers to develop new therapeutic drugs that inhibit PHLPP1 and boost PKC as a means to treat the disease.
March 13, 2019
March 13, 2019 —
New preclinical data from University of California San Diego School of Medicine and Moores Cancer Center offers proof-of-principle for a combination immunotherapy that suppresses tumor growth in the liver. Current therapies for liver cancer are largely ineffective, resulting in poor outcomes.
March 12, 2019
March 12, 2019 —
Every year, at precisely 9 a.m., medical school graduates nationwide find out where they will spend their residencies. On Friday, the 117 members of the 2019 UC San Diego School of Medicine graduating class will be among them.
March 12, 2019
March 12, 2019 —
U.S. News & World Report today released its 2020 guidebook that ranks the nation’s top graduate programs and professional schools, giving high marks to UC San Diego’s innovative programs.
March 7, 2019
March 7, 2019 —
Researchers at UC San Diego School of Medicine generated a new mouse model that mimics human acne for the first time, and used it to validate the concept of “good” and “bad” acne bacteria and introduce new possibilities for targeted treatments and vaccines.
